NUCLEAR TRANSPORT REGULATOR AND USE THEREOF - SHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD

Title:

NUCLEAR TRANSPORT REGULATOR AND USE THEREOF

Document Type and Number:

WIPO Patent Application WO/2023/134629

Kind Code:

A1

Abstract:

The present disclosure relates to the field of drugs. Specifically, the present disclosure relates to a compound as represented by formula (I), or a stereoisomer, tautomer, metabolite, pharmaceutically acceptable salt or prodrug of the compound as represented by formula (I).

More Like This:

JP2014198727	PDE10 INHIBITOR AND RELATED COMPOSITION AND METHOD
JP2013518060	Hepatitis C virus inhibitor
JP2972150	INDUSTRIAL APPLICABILITY The sulfate of the substituted triazole, its pharmaceutical composition and its use in treatment.

Inventors:

LI XIN (CN)
ZHU WEIXING (CN)

Application Number:

PCT/CN2023/071324

Publication Date:

July 20, 2023

Filing Date:

January 09, 2023

Export Citation:

Click for automatic bibliography generation Help

Assignee:

SHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD (CN)
YANGTZE RIVER PHARM GROUP CO (CN)

International Classes:

A61K31/4196; C07D413/14; A61K31/497; A61P29/00; A61P35/00; C07D249/08; C07D403/12

Domestic Patent References:

WO2022089629A1	2022-05-05
WO2017117529A1	2017-07-06

Foreign References:

CN105339358A	2016-02-17
CN113045550A	2021-06-29
CN113248474A	2021-08-13

Other References:

SEXTON RACHEL, MAHDI ZAID, CHAUDHURY RAHMAN, BEYDOUN RAFIC, ABOUKAMEEL AMRO, KHAN HUSAIN Y., BALOGLU ERKAN, SENAPEDIS WILLIAM, LAN: "Targeting Nuclear Exporter Protein XPO1/CRM1 in Gastric Cancer", INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. 20, no. 19, 28 September 2019 (2019-09-28), pages 4826, XP093079680, DOI: 10.3390/ijms20194826

Attorney, Agent or Firm:

TSINGYIHUA INTELLECTUAL PROPERTY LLC (CN)

Download PDF:

View/Download PDF PDF Help

Previous Patent: TRANSMISSION METHOD AND APPARATUS, AND DEVICE

Next Patent: POLICY CONFIGURATION METHOD AND APPARATUS